How to Buy Marker Therapeutics Stock
Marker Therapeutics Inc
Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States.
Marker Therapeutics stock last closed at $1.19, down 0.83% from the previous day, and has decreased 71.6% in one year. It has overperformed other stocks in the Biotechnology industry by 0.05 percentage points. Marker Therapeutics stock is currently +25.26% from its 52-week low of $0.95, and -80.13% from its 52-week high of $5.99.
At the moment, there are 10.71M MRKR shares outstanding. The market capitalization of MRKR is $12.74M. In the past 24 hours, 41,152 MRKR shares were traded.
How to Buy Marker Therapeutics Stock
Wondering how to invest in Marker Therapeutics stock? Here's how.
- Choose where to buy Marker Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Marker Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Select your payment method and add your information.
- Evaluate Marker Therapeutics stock: The Marker Therapeutics ticker symbol is MRKR. Is Marker Therapeutics stock a good investment? Should you buy shares of MRKR? How do MRKR's underlying business fundamentals look? Do top analysts think Marker Therapeutics is a good buy? Why has MRKR's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if MRKR is a good stock to buy).
- Place your MRKR purchase: Decide if you will purchase MRKR shares at the current market price or use a limit order to purchase MRKR shares at a specific price.
- Get notifications regarding your MRKR position: Create a watchlist to important notifications about your position in Marker Therapeutics shares.
Step 1: Choose where to buy Marker Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy MRKR stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy MRKR today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've finished signing up on the best stock investing app, your next step is to transfer the money for your investment:
Watch the tutorial below if you need help transferring funds into your brokerage account.
Step 4: Evaluate Marker Therapeutics stock
Once you have selected the best place to buy Marker Therapeutics stock, it's absolutely critical to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Marker Therapeutics quick stats
MRKR Due Diligence Score
WallStreetZen was built to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on MRKR's stock page.
Is MRKR stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge MRKR's true value.
Using relative valuations measures:
- MRKR may be undervalued based on its P/B ratio of 0.69x, relative to Biotechnology industry P/B ratio of 4.16x
You can do additional valuation research on MRKR's stock here.
A look at MRKR Cashflows and Balance Sheet
Passed Health Checks:
- MRKR has cash burn of 10910324. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the MRKR balance sheet.
- MRKR has a low debt to equity ratio of 0.19.
- There are more short-term assets than short-term liabilities on the MRKR balance sheet.
- MRKR has $19.19M in cash and short term investments. This is sufficient to cover its annual cash burn of $10.91M.
Failed Health Checks:
- Total MRKR debt is higher than 5 years ago, relative to shareholder equity.
- MRKR profit margin has gone up by 0.86 percentage points in the past year, but the company is still unprofitable.
Is MRKR stock a Buy, Hold, or Sell, according to analysts?
Out of 2 Equities analysts who track MRKR, the consensus analyst rating on Marker Therapeutics is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Marker Therapeutics stock forecast page.
MRKR Trading Indicators
MRKR Growth Metrics
Last year, MRKR revenue was $6.59M. Over the last 5 year, MRKR's revenue has gone up by 98.63% per year. This was faster than the Biotechnology industry average of 44.4%.
You can analyze MRKR's earnings and revenue performance here.
Latest Insiders Trades at MRKR
Over the last year, insiders at MRKR have bought more shares than they have sold.
Steve Elms, Director of MRKR, was the latest MRKR insider to buy. They bought $35,472.00 worth of MRKR shares on Dec 23, 2024.
Learn more about who owns MRKR stock here.
Can I rely on MRKR as an income stream?
No, Marker Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your MRKR purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your MRKR position
Now that you own some MRKR stock, you'll want to stay up-to-date on your new stock purchase.
Make a watchlist to keep tabs on your MRKR stock.
MRKR Feed
How to Buy Stock in Marker Therapeutics
To summarize, here are the 6 steps to buy Marker Therapeutics stock:
- Choose where to buy Marker Therapeutics stock
- Create your brokerage account
- Fund your brokerage account
- Evaluate Marker Therapeutics stock
- Place your MRKR purchase
- Get notifications regarding your MRKR position
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Marker Therapeutics, add MRKR to your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.